Scroll down or click here for full Conference Calendar.
The conference will delve into on-body device design and development, enhancing digital connectivity for injectable devices, strategic approaches to wearable device design, regulatory considerations and primary container considerations for large volume delivery systems. It will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry.
Regulators in North America and Europe are requiring stricter standards for environmental monitoring systems, facility cleaning and disinfectant qualification, aseptic cleanroom operations, filtration, sterilisation, and aseptic process simulation (or media fill). The Aseptic Processing Summit includes expert insight into the robust aseptic processing requirements facing the industry, and covers implementation and management of best practice aseptic, barrier, containment, and aseptic technologies.
More than 600 representatives from pharma, biotech and the drug delivery industries gather annually at the PODD: Partnership Opportunities in Drug Delivery conference to assess delivery needs, latest trends, information on deals and to learn about a wide range of innovative technologies. PODD provides business development opportunities through organised networking and a partnering tool for new, emerging and established collaborations.
The 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference returns to Europa. Under the theme "20 Years of Innovation in Drug Delivery - What's next?" we are celebrating the 20th conference edition. Await scientific presentations from regulatory authorities and industry, ample discussions as well as multiple networking opportunities.
In collaboration with the likes of Takeda, Sanofi, Gilead, and Regeneron, this year’s Injectables summit will ensure you walk away with practical tips and set your device program up for success in 2024:
- Innovating next-generation devices
- Updates on the global regulatory landscape
- 20+ case studies, including ultra-high volume devices
- Streamlining end-to-end device development
This conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. We will focus closely on the keys to satisfying recent revisions to several applicable USP chapters, FDA guidances & other international regulatory requirements for best practices in materials and chemistry characterization for drugs, biologics, delivery systems, and primary & secondary packaging.
Smithers have been organising of the Extractables & Leachables conferences for over 15 years, ensuring that this conference will provide you with current information and a great conference experience. Given the current scrutiny paid by governing bodies, understanding the best practice to carry out extractables and leachables studies is imperative in order to eliminate risk and potential development delays.
The 2nd Lipid Nanoparticle Development Europe Summit is committed to equipping you with actionable takeaways across end-to-end characterisation, biodistribution, formulation and scale up to supercharge your LNP pipeline development with therapeutic promise to patients. Built in collaboration with CPI, Pfizer, GSK, this 3-day summit will reunite 100+ senior leaders, sharing exclusive data to help you maximise this non-viral delivery system's potential.
Get up-to-date on the latest analytical strategies and regulatory updates at the Extractables & Leachables Conference on December 4-5, 2023, in Prague. Join scientists, toxicologists, and E&L managers to explore risk-based E&L programs, chemical characterization, and toxicological risk assessment. With discussions on medical device materials and custom-made mechanisms, this conference is essential for all involved in E&L. Register now to stay ahead of the curve!
The DDL Conference is a premier international conference covering respiratory drug delivery. It attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts, and comprises lectures, posters and exhibitions with numerous networking opportunities. DDL is a not-for-profit conference and any surplus funds are provided as grants or awards, targeting research and training of the next generation of aerosol and drug delivery scientists.
Advances in digital health and connected devices are revolutionizing the parenteral drug delivery landscape. This two-day summit features expert insight into next-generation CP product development, and the complex quality, safety, and regulatory compliance issues facing the industry. Pharma Ed’s Pre-filled Syringes & Auto-injectors 2023: Exploring the Future of Parenteral Combination Products provides comprehensive coverage of current and future trends in combination product development for injection platforms and devices.
Join the world's leading experts in Inhalation and Respiratory Drug Delivery at the 7th annual conference in Milan, Italy. On March 6-7, 2024, medical, pharmacology, and healthcare specialists will gather to discuss the latest advancements and techniques in respiratory drug delivery. Don't miss this opportunity to expand your knowledge and network with industry leaders. Register now!
DRUG DELIVERY CONFERENCES 2023/2024
THIS CALENDAR REPRESENTS THE MOST RELIABLE, MOST COMPLETE SOURCE FOR LISTINGS
OF QUALITY DRUG DELIVERY-RELEVANT CONFERENCES WORLDWIDE
UPDATED: October 2nd, 2023
** Bold denotes events with which ONdrugDelivery is a Media Partner **
To request inclusion of a drug delivery (or drug delivery-related) event here, email: [email protected].
Important Note: This conference calendar is for information only and lists events organised by third parties. The publisher, Frederick Furness Publishing Ltd, does not organise any of the events listed. Due care has been used in producing this document, but the Publisher makes no claim that it is free from errors. Nor does the Publisher accept liability for the consequences of any decision or action taken (or not taken) as a result of any information presented herein.